Literature DB >> 31267195

Focus on sepsis.

Morten Hylander Møller1,2, Waleed Alhazzani3,4, Manu Shankar-Hari5,6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31267195     DOI： 10.1007/s00134-019-05680-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  20 in total

1.  Public awareness of sepsis is still poor: we need to do more.

Authors:  Steve W Kerrigan; Ignacio Martin-Loeches
Journal:  Intensive Care Med       Date:  2018-07-19       Impact factor: 17.440

2.  The Surviving Sepsis Campaign Bundle: 2018 update.

Authors:  Mitchell M Levy; Laura E Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2018-04-19       Impact factor: 17.440

3.  Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials.

Authors:  Myura Nagendran; James A Russell; Keith R Walley; Stephen J Brett; Gavin D Perkins; Ludhmila Hajjar; Alexina J Mason; Deborah Ashby; Anthony C Gordon
Journal:  Intensive Care Med       Date:  2019-05-06       Impact factor: 17.440

Review 4.  Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis.

Authors:  Sofie Louise Rygård; Ethan Butler; Anders Granholm; Morten Hylander Møller; Jeremy Cohen; Simon Finfer; Anders Perner; John Myburgh; Balasubramanian Venkatesh; Anthony Delaney
Journal:  Intensive Care Med       Date:  2018-05-14       Impact factor: 17.440

Review 5.  Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.

Authors:  William F McIntyre; Kevin J Um; Waleed Alhazzani; Alexandra P Lengyel; Ludhmila Hajjar; Anthony C Gordon; François Lamontagne; Jeff S Healey; Richard P Whitlock; Emilie P Belley-Côté
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

6.  Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).

Authors:  Tobias Welte; R Phillip Dellinger; Henning Ebelt; Miguel Ferrer; Steven M Opal; Mervyn Singer; Jean-Louis Vincent; Karl Werdan; Ignacio Martin-Loeches; Jordi Almirall; Antonio Artigas; Jose Ignacio Ayestarán; Sebastian Nuding; Ricard Ferrer; Gonzalo Sirgo Rodríguez; Manu Shankar-Hari; Francisco Álvarez-Lerma; Reimer Riessen; Josep-Maria Sirvent; Stefan Kluge; Kai Zacharowski; Juan Bonastre Mora; Harald Lapp; Gabriele Wöbker; Ute Achtzehn; David Brealey; Axel Kempa; Miguel Sánchez García; Jörg Brederlau; Matthias Kochanek; Henrik Peer Reschreiter; Matthew P Wise; Bernd H Belohradsky; Iris Bobenhausen; Benjamin Dälken; Patrick Dubovy; Patrick Langohr; Monika Mayer; Jörg Schüttrumpf; Andrea Wartenberg-Demand; Ulrike Wippermann; Daniele Wolf; Antoni Torres
Journal:  Intensive Care Med       Date:  2018-04-09       Impact factor: 17.440

7.  Surviving sepsis campaign: research priorities for sepsis and septic shock.

Authors:  Craig M Coopersmith; Daniel De Backer; Clifford S Deutschman; Ricard Ferrer; Ishaq Lat; Flavia R Machado; Greg S Martin; Ignacio Martin-Loeches; Mark E Nunnally; Massimo Antonelli; Laura E Evans; Judith Hellman; Sameer Jog; Jozef Kesecioglu; Mitchell M Levy; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2018-07-03       Impact factor: 17.440

8.  Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP).

Authors:  Jean-Louis Vincent; Jean-Yves Lefrant; Katarzyna Kotfis; Rahul Nanchal; Ignacio Martin-Loeches; Xavier Wittebole; Samir G Sakka; Peter Pickkers; Rui Moreno; Yasser Sakr
Journal:  Intensive Care Med       Date:  2018-02-15       Impact factor: 17.440

9.  Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates.

Authors:  Harm-Jan de Grooth; Jonne Postema; Stephan A Loer; Jean-Jacques Parienti; Heleen M Oudemans-van Straaten; Armand R Girbes
Journal:  Intensive Care Med       Date:  2018-03-15       Impact factor: 17.440

10.  Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between National Health Systems: secular trends in sepsis and infection incidence and mortality in Germany.

Authors:  C Fleischmann-Struzek; A Mikolajetz; D Schwarzkopf; J Cohen; C S Hartog; M Pletz; P Gastmeier; K Reinhart
Journal:  Intensive Care Med       Date:  2018-10-04       Impact factor: 17.440
View more
  3 in total

Review 1.  Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.

Authors:  Ivo Udovicic; Ivan Stanojevic; Dragan Djordjevic; Snjezana Zeba; Goran Rondovic; Tanja Abazovic; Srdjan Lazic; Danilo Vojvodic; Kendrick To; Dzihan Abazovic; Wasim Khan; Maja Surbatovic
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

2.  Risk factors for the prognosis of patients with sepsis in intensive care units.

Authors:  Xiaowei Gai; Yanan Wang; Dan Gao; Jia Ma; Caijuan Zhang; Qiuyan Wang
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

Review 3.  Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy.

Authors:  Lucas M Fleuren; Thomas L T Klausch; Charlotte L Zwager; Linda J Schoonmade; Tingjie Guo; Luca F Roggeveen; Eleonora L Swart; Armand R J Girbes; Patrick Thoral; Ari Ercole; Mark Hoogendoorn; Paul W G Elbers
Journal:  Intensive Care Med       Date:  2020-01-21       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.